Table 2. Observed outcomes for the whole cohort, and for men and women separately.
| Whole cohort (n = 501,331) | Men (n = 228,594) | Women (n = 272,737) | |
|---|---|---|---|
| All-cause mortality | 20,126 (4.0%) | 12,137 (5.3%) | 7,989 (2.9%) |
| CVD mortality | 4,197 (0.8%) | 3,069 (1.3%) | 1,128 (0.4%) |
| IHD mortality | 2,285 (0.5%) | 1,877 (0.8%) | 408 (0.1%) |
| Fatal AMI | 920 (0.2%) | 741 (0.3%) | 179 (0.1%) |
| Incident AMI | 8,605 (1.7%) | 6,069 (2.7%) | 2,536 (0.9%) |
| Cancer mortality | 11,167 (2.2%) | 6,041 (2.6%) | 5,126 (1.9%) |
| Follow-up (days): median [IQR] | |||
| Death | 9.0 [8.2–9.7] | 8.9 [8.2–9.7] | 9.0 [8.3–9.7] |
| AMI | 8.1 [7.5–8.8] | 8.1 [7.4–8.8] | 8.2 [7.5–8.8] |
*Results are presented as number of outcomes (percentage). AMI: acute myocardial infarction; CVD: cardiovascular disease; IHD: ischaemic heart disease; IQR: interquartile range.